Statistiche web
July 16, 2025

Company’s

Flutterwave Named Fast Company’s Most Innovative Company for Europe, Middle East, and Africa 2024 Flutterwave Named Fast Company’s Most Innovative Company for Europe, Middle East, and Africa 2024

Flutterwave Named Fast Company’s Most Innovative Company for Europe, Middle East, and Africa 2024

Karren Franco March 20, 2024
Africa’s leading payments technology company, Flutterwave, joins the ranks of Nvidia, YouTube, Taco Bell, and more. SAN...
Read More Read more about Flutterwave Named Fast Company’s Most Innovative Company for Europe, Middle East, and Africa 2024
SolarWinds to Host EMEA Transform Partner Summit, Emphasizing Company’s Commitment to Channel Partners SolarWinds to Host EMEA Transform Partner Summit, Emphasizing Company’s Commitment to Channel Partners

SolarWinds to Host EMEA Transform Partner Summit, Emphasizing Company’s Commitment to Channel Partners

NewsVoir February 7, 2024
Lisbon event brings partners together to hear from SolarWinds executive leadership on partner program updates, product innovations,...
Read More Read more about SolarWinds to Host EMEA Transform Partner Summit, Emphasizing Company’s Commitment to Channel Partners
Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform Auto Draft

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

Karren Franco January 25, 2023
WARREN, N.J. — Tevogen Bio today announced positive topline results from its Proof-of-Concept (POC) clinical trial designed to evaluate the safety...
Read More Read more about Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

You may have missed

Hikma, IFC sign 0mn deal, marking a 40-year partnership driving access to quality medicines in the MENA region

Hikma, IFC sign $250mn deal, marking a 40-year partnership driving access to quality medicines in the MENA region

Karren Franco July 16, 2025
Shapoorji Pallonji brings 158 years of luxury real estate expertise to the UAE

Shapoorji Pallonji brings 158 years of luxury real estate expertise to the UAE

Karren Franco July 15, 2025
Lincoln Rise Launches Landmark Wellness-Centric Residential Project in Dubai South

Lincoln Rise Launches Landmark Wellness-Centric Residential Project in Dubai South

Karren Franco July 15, 2025
Simplified Car Ownership for New Residents and First-Time Buyers

Simplified Car Ownership for New Residents and First-Time Buyers

Karren Franco July 15, 2025